Chronic Thromboembolic Pulmonary Hypertension Secondary to Thrombophilia and Incidentally Diagnosed Atrial Septal Defect

Autor: Mehmet Kilinc, Yalin Tolga Yaylali, Serpil Taş, Bedrettin Yildizeli

Publikováno v: JACC: Case Reports, Vol 2, Iss 4, Pp 658-661 (2020)
JACC Case Reports

A 46-year-old man developed chronic thromboembolic pulmonary hypertension and atrial fibrillation after acute pulmonary embolism. He was found incidentally to have an isolated secundum atrial septal defect, as well as a homozygous mutation for the pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6405e6cbdebb742eba90277f95cc1ba
http://www.sciencedirect.com/science/article/pii/S2666084920301078

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice

Autor: Graham J. Dockray, Susan Kenny, Joanne Gamble

Publikováno v: Regulatory Peptides

The intestinal hormone cholecystokinin (CCK) delays gastric emptying and inhibits food intake by actions on vagal afferent neurons. Recent studies suggest plasminogen activator inhibitor (PAI)-1 suppresses the effect of CCK on food intake. In this st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbd0cd88aa20003f18e5c8ec01c61794

Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype.

Autor: Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Duchez AC; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Simard T; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Dhaliwal S; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Gillmore T; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Di Santo P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Labinaz A; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Ramirez FD; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Rasheed A; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Robichaud S; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Ouimet M; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Short S; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Clifford C; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Xiao F; Kidney Research Centre, Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Lordkipanidzé M; Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada.; Research Center, Montreal Heart Institute, Montréal, Québec, Canada., Burger D; Kidney Research Centre, Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Gadde S; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Rayner KJ; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Hibbert B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Publikováno v: JACC. Basic to translational science [JACC Basic Transl Sci] 2022 Sep 21; Vol. 7 (10), pp. 985-997. Date of Electronic Publication: 2022 Sep 21 (Print Publication: 2022).

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer.

Autor: Cameron AC; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., McMahon K; McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Hall M; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Neves KB; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Rios FJ; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Montezano AC; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Welsh P; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Waterston A; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., White J; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Mark PB; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Touyz RM; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Lang NN; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2020 Sep; Vol. 2 (3), pp. 443-455.